Regression to the mean: A limited issue in disease management programs for chronic obstructive pulmonary disease

Disease Management

Volumn 11, Issue 2, 2008, Pages 103-110

  Tinkelman, David ^a   Wilson, Steve ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMERGENCY WARD; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL RESEARCH; POPULATION RESEARCH; SCHOOL CHILD;

AGED; CASE-CONTROL STUDIES; COLORADO; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MEDICAID; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; UNITED STATES;

EID: 42449099550     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2008.112729     Document Type: Article

References (18)

1. Chronic Obstructive Pulmonary Disease. Data Fact sheet. Bethesda, MD: National Heart, Lung, and Blood Institute; March 2003. Available at: 〈www.nhlbi.nih.gov/health/public/lung/other/copd_fact.pdf〉. Accessed on January 14, 2008.
2. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: Final data for 2002. Natl Vital Stat Rep. 2004;53:1-115.
3. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD. Deaths: Final data for 2001. Natl Vital Stat Rep. 2003;52:1-115.
4. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J. 2006;28:523-532.
5. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
6. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10. 2006;(232):1-153.
7. Tinkelman DG, George D, Halbert RJ. Chronic obstructive pulmonary disease in patients under age 65: Utilization and costs from a managed care sample. J Occup Environ Med. 2005;47:1125-1130.
8. Linden A. Estimating the effect of regression to the mean in health management programs. Dis Manage and Health Outc. 2007;15:7-12.
9. Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ. 2003;326:1083-1084.
10. Morton V, Torgerson DJ. Regression to the mean: Treatment effect without the intervention. J Eval Clin Pract. 2005;11:59-65.
11. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: What it is and how to deal with it. Int J Epidemiol. 2005;34:215-220.
12. Enck P, Klosterhalfen S. The placebo response in functional bowel disorders: Perspectives and putative mechanisms. Neurogastroenterol Motil. 2005;17:325-331.
13. Klosterhalfen S, Enck P. Psychobiology of the placebo response. Auton Neurosci. 2006;125:94-99.
14. Tinkelman D, Wilson S. Asthma disease management: Regression to the mean or better? Am J Manag Care. 2004;10:948-954.
15. Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet. 1996;347:241-243.
16. Linden A, Adams JL, Roberts N. Evaluating disease management programme effectiveness: An introduction to the regression discontinuity design. J Eval Clin Pract. 2006;12:124-131.
17. Gosse P, Sheridan DJ, Zannad F, et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: The LIVE study. J Hypertens. 2000;18:1465-1475.
18. Gosse P, Dubourg O, Gueret P. Regression of left ventricular hypertrophy with echocardiography: Some lessons from the LIVE study. J Hypertens. 2003;21:217-221.